NMN for longevity
Grade ANicotinamide Mononucleotide is a direct NAD+ precursor implicated in mitochondrial function, DNA repair, and sirtuin activity.
Nicotinamide Mononucleotide is a direct NAD+ precursor implicated in mitochondrial function, DNA repair, and sirtuin activity.
Phosphorylated nicotinamide ribose converted intracellularly to NAD+ via NMNAT enzymes; supports CD38, SIRT1/3, and PARP-dependent pathways.
NMN is typically taken orally as sublingual powder or enteric capsule, morning, before training. Phosphorylated nicotinamide ribose converted intracellularly to NAD+ via NMNAT enzymes; supports CD38, SIRT1/3, and PARP-dependent pathways. Effective range is 125 mg – 1,000 mg, with 250–500 mg AM being the most-studied dose. It does not require food, and fasted dosing is often preferred for absorption or timing reasons.
Morning or pre-training dosing aligns NMN with circadian cortisol rise and training demand. This maximises subjective energy effects and avoids sleep interference.
Grade A — multiple randomised human trials or meta-analyses support the primary claim. Dosing, mechanism and safety are well characterised in humans.
The primary references used to grade NMN are listed below. Cross-check against the current literature and expect the grade to move as new human trials publish.
Further reading: Research library → · Protocols →
Common questions about dose, benefits, side effects and longevity use of NMN.
250–500 mg AM is the most-studied dose, with a full effective range of 125 mg – 1,000 mg. Take it morning, before training.
Phosphorylated nicotinamide ribose converted intracellularly to NAD+ via NMNAT enzymes; supports CD38, SIRT1/3, and PARP-dependent pathways.
Subjective effects can appear in 1–3 weeks. Objective biomarker shifts typically require 8–12 weeks of consistent dosing, which is why baseline and 12-week labs are recommended.
Food is not required for NMN. Many users prefer fasted dosing to keep timing consistent, but taking it with a light snack is fine.
Mild nausea at high doses; Flushing (rare). Avoid in: Active malignancy (theoretical), Pregnancy (insufficient data).
Most users run NMN continuously and reassess every 12 weeks. A short wash-out can restore responsiveness if effects plateau. Long-term dosing should be paired with periodic bloods.
Commonly stacked with: TMG (trimethylglycine), Resveratrol, Pterostilbene. Introduce one compound at a time to preserve attribution of effect and side effect.
Look for third-party testing (NSF, Informed Sport, USP), a standardised active compound on the label, a clear country of origin, and dose-per-serving that matches the researched range.
| Attribute | NMNThis page | Urolithin A | Creatine Monohydrate |
|---|---|---|---|
| Evidence | Grade A87/100 | Grade B71/100 | Grade A94/100 |
| Category | Mitochondrial | Mitochondrial | Cognition |
| Best for | Restored NAD+ in aged tissues | Improved muscle endurance in middle-aged adults (RCT) | Strength and lean mass |
| Typical dose | 250–500 mg AM | 500 mg AM | 5 g daily |
| Timing | Morning, before training | Morning, with or without food | Any time of day, consistent |
| Form | Sublingual powder or enteric capsule | Capsule (Mitopure / synthetic urolithin A is most-studied) | Micronized powder |
| Action | Current page | View → | View → |